Potential salivary markers for differential diagnosis of crohn’s disease and ulcerative colitis

22Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

The properties of the saliva of patients with inflammatory bowel disease (IBD) are poorly recognized. Likewise, the diagnostic potential of saliva for differentiating various forms of IBD is largely unexplored. Therefore, we compared the concentrations of several parameters in unstimulated whole mixed saliva collected in a standardized manner from patients with active IBD unresponsive to conventional therapy. The samples were received from 27 patients with Crohn’s disease (CD), 24 patients with ulcerative colitis (UC), and 51 healthy individuals. Compared to the controls, the salivary concentrations of S100A8/calprotectin, myeloperoxidase, and IgA were significantly decreased in both CD and UC patients. In addition, patients with UC had decreased levels of TNF-R1 and decreased catalase activity. Interestingly, the concentrations of myeloperoxidase and TNF-R1 showed a high differentiation potential for CD and UC (AUC = 0.690 and 0.672, respectively). All these findings are discussed in the context of host defense in the oral cavity, patients’ prior treatment regimens, and smoking habits.

Cite

CITATION STYLE

APA

Nijakowski, K., Rutkowski, R., Eder, P., Simon, M., Korybalska, K., Witowski, J., & Surdacka, A. (2021). Potential salivary markers for differential diagnosis of crohn’s disease and ulcerative colitis. Life, 11(9). https://doi.org/10.3390/life11090943

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free